SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as investors gear up for the presentation of long-term Phase 3 VELA trial data at the upcoming American Academy of Dermatology (AAD) meeting, which is widely expected to validate sonelokimab as a best-in-class treatment for hidradenitis suppurativa. Community sentiment remains heavily bullish, with active discussions focusing on anticipated institutional accumulation, potential M&A activity involving major pharmaceutical suitors, and the company's path toward BLA submission later this year.

BlockDAG is a hybrid concept that combines features of both traditional blockchains and DAGs. It retains the benefits of DAGs, such as high scalability and faster transaction processing, while integrating the security and trust of blockchain consensus mechanisms. BlockDAG emerges as a groundbreaking solution, meticulously merging the strengths of both blockchain and DAG architectures. It leverages the robust security and decentralization of blockchains while incorporating the efficient, scalable transaction processing of DAGs. This strategic integration allows blockDAG to handle a significantly higher volume of transactions at faster speeds compared to traditional blockchains. By overcoming the inherent limitations of both technologies, blockDAG paves the way for a future where distributed ledgers can seamlessly scale to meet the ever-growing demands of the cryptocurrency and broader digital landscape.

BlockDAG

BlockDAG is currently facing intense scrutiny and widespread accusations of being a sophisticated scam, driven by severe community frustration over inaccessible tokens, failed claim processes, and suspicious exchange activity. Investors are actively debating the legitimacy of the project as they vent about missing balances, lack of functional contracts, and concerns that early access programs unfairly privilege insiders over retail participants.

Vanguard Index Funds - Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is trending as investors weigh persistent geopolitical uncertainty and fiscal policy concerns against the broader strength of U.S. markets. Community discourse remains heavily polarized, with many users debating the impact of ongoing administration conflicts on long-term portfolio stability and the relative merits of broad index-based strategies versus active trading.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is currently a major focus for traders who are monitoring the development of its 11GW Project Matador campus, with significant community discourse revolving around the anticipated announcement of an anchor tenant. Investors are weighing high-conviction bullish cases involving institutional support and power infrastructure demands against concerns over stock volatility, ongoing class action headlines, and the need for definitive contract signings to validate the company's long-term valuation.

KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa. The company was founded by T. Andrew Crockett, Edward P. Feener, and Lloyd Paul Aiello on March 26, 2004 and is headquartered in Framingham, MA.

KalVista Pharmaceuticals Inc

KalVista Pharmaceuticals is trending due to the anticipation surrounding the imminent FDA approval of its oral hereditary angioedema (HAE) treatment, with the community closely tracking potential label discussions and regulatory updates. Investors are actively discussing the stock's significant institutional ownership and high short interest, positioning it as a potential candidate for a volatile breakout as the revised PDUFA window approaches.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros is experiencing heightened volatility and intense debate among investors as they approach their upcoming earnings announcement, with many closely tracking the company's aggressive store expansion versus the risks posed by its high valuation in a competitive retail landscape. While some market participants express concern over potential share dilution and inflationary pressures on consumer spending, the community is actively buzzing over strong unit-level economics and the company's ability to maintain long-term growth momentum.

Borr Drilling Ltd. engages in the provision of offshore drilling services to the oil and gas industry. It operates through Dayrate; and Integrated Well Services (IWS) segments. The Dayrate segment consists of rig charters and ancillary services. The IWS segment provides integrated well services through Opex and Akal. The company was founded by Tor Olav Trøim on August 8, 2016 and is headquartered in Hamilton, Bermuda.

Borr Drilling Ltd

Borr Drilling is capturing market attention as investors weigh the impact of recent contract expansions and a transition in executive leadership against persistent debt concerns. The community remains divided, with many traders actively accumulating shares based on potential upside in the offshore rig market, while others express caution regarding the company's long-term financial leverage.

iShares Trust - iShares India 50 ETF

iShares India 50 ETF

The iShares India 50 ETF is drawing investor attention as markets grapple with mixed signals from shifting trade policy, fluctuating oil prices, and intense volatility across key sectors. Community sentiment remains deeply divided, with discussions oscillating between caution over recent foreign outflows and opportunistic buying strategies amid structural growth projections.

iShares Trust - iShares MSCI India ETF

iShares MSCI India ETF

The iShares MSCI India ETF (INDA) is currently in focus as investors weigh the potential impact of looming U.S. reciprocal tariffs and geopolitical tensions against the nation's robust long-term growth story and ongoing trade deal negotiations. While market participants are actively discussing the risks of foreign equity outflows and currency volatility, many community members remain bullish on India's resilience and its strategic potential as a global manufacturing hub.

Rio Tinto Plc engages in the exploration, mining, and processing of mineral resources. It operates through the following business segments: Iron Ore, Aluminium, Copper, and Minerals. The Iron Ore segment supplies iron ore mining and salt and gypsum production. The Aluminium segment produces bauxite, alumina and primary aluminum. The Copper segment offers gold, silver, molybdenum and other by-products. The Minerals includes businesses with products such as uranium, borates, salt and titanium dioxide feedstock together with coal operations. The Other Operations segment covers the curtailed Gove alumina refinery and Rio Tinto Marine operations. The company was founded in 1873 and is headquartered in London, the United Kingdom.

Rio Tinto plc - ADR

Rio Tinto plc

Rio Tinto is drawing significant investor attention due to the finalized acquisition of Arcadium Lithium and a strategic focus on expanding its U.S. copper footprint, highlighted by the fast-tracking of its Resolution Copper project. While the stock navigates iron ore price volatility and ongoing geopolitical trade concerns, the community remains bullish on its long-term commodity cycle prospects and its transition into critical battery minerals.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FOXO Technologies, Inc. ($FOXO) stock jumped about 58% on Thursday after the Minneapolis, Minnesota-based epigenetic biomarkers technology solutions company confirmed the schedule for its special meeting of shareholders.The company said in a release that the virtual meeting will take place on Friday at 10:30 a.m. ET, as previously announced.The FOXO board requested shareholders vote in favor of the proposals on the proxy card. According to the proxy statement filed with the SEC earlier this month, the company seeks approval for issuing shares equal to or exceeding 20% of its Class A common stock.&nbsp;The company said the common stock would be used to redeem its Series A convertible preferred stock.In mid-December, the company announced a series of&nbsp;capital raising transactions to improve the balance sheet, satisfy minimum stockholders’ equity requirements of the NYSE American exchange and provide capital for growth and reduce outstanding liabilities.These transactions included its subsidiary Renova Health exchanging about $21 million of senior, secured notes issued by it into 21,000 Series A convertible redeemable preferred stock of FOXO. and an institutional investor investing an additional $1 million funding and exchanging $2.2 million debt into 2,464 preferred stock.Seamus Lagan, who was appointed as CEO last month, said, “This meeting will complete the obligations from the acquisition agreements that the Company has completed in recent months."“We look forward to a successful outcome to the meeting and believe the transformation of FOXO in the second half of 2024 creates a new foundation on which we can build a significant and valuable company for the benefit of our shareholders.”<figure class="image"><img style="aspect-ratio:635/137;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/foxo_sentiment_58c5308c5b.png" alt="foxo-sentiment.png" width="635" height="137"><figcaption>FOXO sentiment and message volume January 16, 2025, as of 11:27 pm ET | Source:&nbsp;Stocktwits</figcaption></figure>On Stocktwits, retail sentiment toward FOXA stock improved to ‘extremely bullish’ (97/100), matching the high seen in late-May, from ‘bullish’ a day ago. Message volume also spiked to ‘extremely high’ levels.A retail watcher of the stock on the platform predicted more strength if volume increases.<stembedurl>https://stocktwits.com/HairyBagHolder/message/600418643</stembedurl>Another flagged a buying opportunity, citing technicals.<stembedurl>https://stocktwits.com/ATerragna/message/600397603</stembedurl><a href="https://stocktwits.com/symbol/FOXO">FOXO stock</a> settled Thursday’s session up 57.97% at $0.3150 but fell about 8% in after-hoursFor updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/palantir-stock-in-spotlight-following-reports-of-investment-in-drone-startup-muted-analyst-commentary/chGvmwIRnY">Palantir Stock In Spotlight Following Reports Of Investment In Drone Startup, Muted Analyst Commentary: Retail Remains On Sidelines</a>

Nano-Cap FOXO Surges as Retail Frenzy Builds Ahead of Friday’s Special Shareholder Meeting

FOXO seeks approval for issuing shares equal to or exceeding 20% of its Class A common stock. 

Equity

FOXO seeks approval for issuing shares equal to or exceeding 20% of its Class A common stock. 


FOXO Technologies, Inc. develops genetic sequencing technology, artificial intelligence and bioinformatics tools. It operates through the FOXO Labs and FOXO Life segments. The FOXO Labs segment is involved in research and development and is commercializing proprietary epigenetic biomarker technology. The FOXO Life segment is involved in combining life insurance with a dynamic molecular health and wellness platform. The company was founded on April 27, 2020 and is headquartered in West Palm Beach, FL.

FOXO Technologies Inc - Ordinary Shares - Class A

Peloswing

JFDI

ACInvestorBlog

GPaisa

A pillar of the Stocktwits ecosystem. This award recognizes the member who fosters connection, shares invaluable insights, and elevates the daily discussion to empower their fellow traders, on-platform.

FOXO
FOXO Technologies Inc

Feed

News

Sentiment

Fundamentals

Info

Latest FOXO News

FOXOFOXO Technologies Inc